glp-1 prescriptions growth slowing 2024 RA prescription trends: January 2018 – December Pharma Giants Bet on Next-Generation
Description
Appendicitis occurred one week after the initiation of Tirzepatide, which demonstrates a temporal association between this medication and appendicitis
Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis
doi: 10.1083/jcb.201004062
The committee has agreed further lists of questions to be addressed by the respective marketing authorisation holders for these medicines. In July 2023, the MHRA launched its own review into the risk of suicidal thoughts and thoughts of self-harm associated with GLP-1 RAs
